Physician
Gastroenterology
Dr. Mark A. Titus, MD
|
|
Give Review
Mark Titus practices Gastroenterology. He researched medicine at Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76/0 in Research/PrimaryCare. Mark A. Titus is also a published physician. He has 17 publication published. The most recent publication is: Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer. Dr. Mark A. Titus accepts Medicare payments and is listed with Medicare.gov.
Publications
- Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer.
- Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate Cancer.
- 5α-reductase type 3 enzyme in Benign and malignant prostate.
- Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone.
- 5?-reductase type 3 expression in human Benign and malignant tissues: a comparative analysis during prostate cancer progression.
- Potential prostate Cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone.
- Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate Cancer.
- Androgen quantitation in prostate Cancer tissue using liquid chromatography tandem mass spectrometry.
- 5α-reductase type 3 expression in human Benign and malignant tissues: A comparative analysis during prostate cancer progression.
- Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate Cancer.
- 14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer.
- Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer.
- 5alpha-androstane-3alpha,17beta-diol supports human prostate Cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implicati...
- Testosterone and dihydrotestosterone tissue levels in recurrent prostate Cancer.
- Steroid 5alpha-reductase isozymes I and II in recurrent prostate Cancer.
- Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt ph...
Schools
UmdnjNew Jersey Med Sch
Vanderbilt Medical Center
University Of Maryland
Duke University
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Education
-
Vanderbilt University -
Rutgers New Jersey Medical School
Drug Facts
| NPI NUMBER | 1942204219 | |
| NPPES Provider LastName | TITUS | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 236061393 | |
| NPPES Provider State | VA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 559.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942204219 |
| Last Name Of The Provider | TITUS |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Jin X. Zhang, MD |
|
Dr. Mitchell L. Shiffman, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. William A. Hackworth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth A. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa Odabasi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Stephens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Boyd, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamed B. El Safadi, MD
This Doctor is OpenDoctor Recommended.
|